BlackRock Advisors’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

BlackRock Advisors’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2K	Hold	5,847	–	–	﹤0.01%	3682
2016 Q3	$5K	Hold	5,847	–	–	﹤0.01%	3647
2016 Q2	$6K	Buy	+5,847	New	+$5.01K	﹤0.01%	3651

Other funds holding CLRBZ

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

BlackRock Advisors's CLRBZ Position: Q4 2016 in Review

BlackRock Advisors held its Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) position steady in Q4 2016 at 5,847 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3682.

BlackRock Advisors first reported a position in CLRBZ in Q2 2016 and has held it in 3 quarters since. The position peaked at $6K in Q2 2016. 4 funds tracked by Wall St. Rank hold CLRBZ as of Q4 2016.

BlackRock Advisors held 5,847 shares of Cellectar Biosciences, Inc. Series A Warrants worth $2K as of Q4 2016.
BlackRock Advisors left its Cellectar Biosciences, Inc. Series A Warrants share count unchanged in Q4 2016.
Cellectar Biosciences, Inc. Series A Warrants made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3682 holding.
BlackRock Advisors first reported a position in Cellectar Biosciences, Inc. Series A Warrants in Q2 2016 and has held it in 3 quarters since.
BlackRock Advisors's Cellectar Biosciences, Inc. Series A Warrants position peaked at $6K in Q2 2016.
4 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.